LCM
GILD icon

Leonard Capital Management’s Gilead Sciences GILD Stock Holding History

Leonard Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-29,000
Closed -$2.94M – 14
2015
Q4 		$2.94M Buy
+29,000
New +$3.02M 2.62% 16
2015
Q3 		– Sell
-40,950
Closed -$4.79M – 28
2015
Q2 		$4.79M Buy
40,950
+10,000
+32% +$1.09M 1.66% 8
2015
Q1 		$3.04M Buy
30,950
+5,950
+24% +$604K 1.04% 37
2014
Q4 		$2.36M Buy
+25,000
New +$2.59M 0.61% 69

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Leonard Capital Management's GILD Position: Q1 2016 in Review

Leonard Capital Management sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 29,000 shares — an estimated $2.94M sold.

Leonard Capital Management first reported a position in GILD in Q4 2014 and held it in 4 quarters. The position peaked at $4.79M in Q2 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Leonard Capital Management reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Leonard Capital Management sold 29,000 Gilead Sciences shares in Q1 2016, an estimated $2.94M.
  • Leonard Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 4 quarters.
  • Leonard Capital Management's Gilead Sciences position peaked at $4.79M in Q2 2015.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Leonard Capital Management's 13F filing for Q1 2016, filed 11 May 2016.